We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$1.22B
Cap. Flow %
-13.56%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.58%
2 Healthcare 3.09%
3 Consumer Discretionary 2.5%
4 Technology 1.62%
5 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSCR icon
1776
Oscar Health
OSCR
$10B
-5,401
Closed -$80.3K
OUST icon
1777
Ouster
OUST
$2.36B
-63,085
Closed -$767K
OVV icon
1778
CALL
Ovintiv
OVV
$18.5B
-10,000
Closed -$428K
OXM icon
1779
Oxford Industries
OXM
$444M
-12,000
Closed -$704K
OXM icon
1780
PUT
Oxford Industries
OXM
$444M
-25,000
Closed -$1.47M
PAHC icon
1781
Phibro Animal Health
PAHC
$1.42B
-100
Closed -$2.14K
PAHC icon
1782
PUT
Phibro Animal Health
PAHC
$1.42B
-100
Closed -$2.14K
PANW icon
1783
Palo Alto Networks
PANW
$307B
-1,800
Closed -$334K
PATH icon
1784
UiPath
PATH
$7.42B
-10,800
Closed -$111K
PCG icon
1785
PUT
PG&E
PCG
$29B
-1,250,000
Closed -$21.5M
PCT icon
1786
PUT
PureCycle Technologies
PCT
$1.12B
-200,000
Closed -$1.38M
PCVX icon
1787
CALL
Vaxcyte
PCVX
$8.81B
-25,000
Closed -$944K
PCVX icon
1788
Vaxcyte
PCVX
$8.81B
-44,200
Closed -$1.67M
PCVX icon
1789
PUT
Vaxcyte
PCVX
$8.81B
-62,800
Closed -$2.37M
PD icon
1790
CALL
PagerDuty
PD
$1.14B
-30,000
Closed -$548K
PDSB icon
1791
CALL
PDS Biotechnology
PDSB
$32.8M
-45,500
Closed -$54.1K
PEG icon
1792
CALL
Public Service Enterprise Group
PEG
$35.1B
-9,600
Closed -$790K
PEP icon
1793
CALL
PepsiCo
PEP
$185B
-100,000
Closed -$15M
PERI icon
1794
Perion Network
PERI
$356M
-7,360
Closed -$59.9K
PFE icon
1795
Pfizer
PFE
$157B
-23,500
Closed -$548K
PFE icon
1796
PUT
Pfizer
PFE
$157B
-350,000
Closed -$8.87M
PGNY icon
1797
Progyny
PGNY
$2.13B
-28,800
Closed -$643K
PHIN icon
1798
Phinia Inc
PHIN
$2.25B
-8,563
Closed -$363K
PHIN icon
1799
PUT
Phinia Inc
PHIN
$2.25B
-37,000
Closed -$1.57M
PHR icon
1800
CALL
Phreesia
PHR
$642M
-8,000
Closed -$204K

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $1.22B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.